F. Karakuş Et Al. , "Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction.," Current computer-aided drug design , 2024
Karakuş, F. Et Al. 2024. Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction.. Current computer-aided drug design .
Karakuş, F., Kuzu, B., Köstekci, S., & Tülüce, Y., (2024). Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction.. Current computer-aided drug design .
Karakuş, Fuat Et Al. "Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction.," Current computer-aided drug design , 2024
Karakuş, Fuat Et Al. "Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction.." Current computer-aided drug design , 2024
Karakuş, F. Et Al. (2024) . "Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction.." Current computer-aided drug design .
@article{article, author={Fuat Karakuş Et Al. }, title={Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction.}, journal={Current computer-aided drug design}, year=2024}